It’s a crucial moment for the cell and gene therapy field. At the American Society of Gene & Cell Therapy’s annual meeting, several trends emerged: In vivo CAR-T is everywhere, CRISPR comes for Alzheimer’s and FDA officials took the stage.

It’s a crucial moment for the cell and gene therapy field. At the American Society of Gene & Cell Therapy’s annual meeting, several trends emerged: In vivo CAR-T is everywhere,…

On Thursday, the American Society of Gene & Cell Therapy (ASGCT) and the Orphan Therapeutics Accelerator (OTXL) debuted a joint clearinghouse for shelved drug programs